Charles River Laboratories Appoints John C. Ho, M.D. as Senior Vice President, Corporate Strategy
January 16 2006 - 10:27AM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL), a
premier global provider of solutions that advance the drug
discovery and development process, today announced that John C. Ho,
M.D. will join the Company effective January 9, 2006, as Senior
Vice President, Corporate Strategy. Reporting directly to Charles
River Chairman, President and CEO, James C. Foster, Dr. Ho will
lead Charles River's worldwide strategic planning process through
implementing and expediting key initiatives underlying the
Company's strategic plan. James Foster stated, "John brings with
him a wealth of business management experience and knowledge in the
life sciences industry that will be critical in furthering our
corporate vision and goals. We are pleased to have him on board to
help us explore new directions and execute the Company's growth
plan." Dr. Ho has over 16 years experience serving pharmaceutical,
biotech, medical device and provider organizations in a variety of
capacities including corporate and M&A strategy formulation,
product commercialization, investment decision making, process
reengineering and organizational redesign. Most recently, he served
as a partner at Accenture in their Health and Life Sciences
Practice where he led the Preclinical Development Practice and the
Medical Device Practice areas. He was also was a leader in the
Discovery Research and Clinical Operations Practices. Prior to
joining Accenture, Dr. Ho spent five years as a partner in the Life
Science Industry Group of Pittiglio Rabin Todd & McGrath and
was at McKinsey and Company. "I am pleased to be joining Charles
River Laboratories, a leader in the life sciences industry with
remarkable assets in its customer base, market-leading products and
services and strong management team. I believe the Company is
poised to play a critical role in the evolution of the
biopharmaceutical industry, helping it to greatly enhance its
productivity and innovation. I am extremely excited to join Charles
River and support the Company's transformation," said Dr. Ho. Dr.
Ho holds a master's degree in business administration from the Amos
Tuck School at Dartmouth College, a degree in medicine from Brown
University School of Medicine and a Bachelor of Science degree from
the Massachusetts Institute of Technology. About Charles River
Laboratories Charles River Laboratories, based in Wilmington,
Massachusetts, U.S., is a global provider of solutions that advance
the drug discovery and development process. Our leading-edge
products and services are designed to enable our clients to bring
drugs to market faster and more efficiently. Backed by our
rigorous, best-in-class procedures and our proven data collection,
analysis and reporting capabilities, our products and services are
organized into three categories spanning every step of the drug
development pipeline: Research Models and Services, Preclinical
Services, and Clinical Services. Charles River's customer base
includes all of the major pharmaceutical companies and many
biotechnology companies, government agencies and leading hospitals
and academic institutions. Charles River's 8,400 employees serve
clients in more than 50 countries. For more information on Charles
River, visit our website at www.criver.com.
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Jul 2023 to Jul 2024